Malaysian Genomics announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the R&D of phytopharmaceutical and biotechnology products that can lead to commercialisation. Kensana Health Canada is a biotechnology specialist focused on the R&D of cannabinoid treatments and management of wounds partnered with a German multinational phytopharmaceutical company. MAHSA…
Malaysian Genomics To Collaborate On Cannabinoid R&D – BusinessToday
2023-02-24T07:08:13-05:00February 24th, 2023|
Related Posts
-
Ministry To Calculate And Evaluate If Gardenia’s Price Increase Is Reasonable
September 28th, 2023 -
It’s All About The Bond Yields
September 28th, 2023 -
MDR Imposed By Paynet Too High, Merchants Could Quit Using QR Payment
September 28th, 2023 -
Singapore Hands Out More Cash To Its Citizens In New Cost Of Living Support Package
September 28th, 2023